Association Between Viewing Health Care Price Information and Choice of Health Care Facility | Health Care Economics, Insurance, Payment | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
1.
Government Accountability Office. Heath Care Transparency: Actions Needed to Improve Cost and Quality Information for Consumers. October 2014. http://www.gao.gov/assets/670/666572.pdf. Accessed February 15, 2015.
2.
Sinaiko  AD, Rosenthal  MB.  Increased price transparency in health care—challenges and potential effects.  N Engl J Med. 2011;364(10):891-894.PubMedGoogle ScholarCrossref
3.
Robinson  JC, Whaley  C, Brown  TT.  Association of reference pricing for diagnostic laboratory testing with changes in patient choices, prices, and total spending for diagnostic tests.  JAMA Intern Med. 2016;176(9):1353-1359.PubMedGoogle ScholarCrossref
4.
Whaley  C, Schneider Chafen  J, Pinkard  S,  et al.  Association between availability of health service prices and payments for these services.  JAMA. 2014;312(16):1670-1676.PubMedGoogle ScholarCrossref
5.
Sinaiko  AD, Rosenthal  MB, Examining  A.  Healthcare price transparency tool: who uses it and how they shop for care.  Health Aff. 2016;35(4):662-670.Google ScholarCrossref
6.
Elixhauser  A, Steiner  C, Harris  DR, Coffey  RM.  Comorbidity measures for use with administrative data.  Med Care. 1998;36(1):8-27.PubMedGoogle ScholarCrossref
Research Letter
December 2016

Association Between Viewing Health Care Price Information and Choice of Health Care Facility

Author Affiliations
  • 1Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
  • 2Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts
JAMA Intern Med. 2016;176(12):1868-1870. doi:10.1001/jamainternmed.2016.6622

In the United States, prices for health care services differ dramatically within a single geographic location, often without commensurate differences in quality.1 Transparency tools that provide price information to help patients identify lower-cost services are a strategy to reduce health care spending.2 Price information in combination with insurance benefit design that shares savings when patients choose low-cost health care facilities (eg, reference pricing) has led to lower spending3; however, the impact of price information on patient choices for patients in commercial insurance without such benefit design incentives is largely unknown. A prior study reported that payments for laboratory tests and advanced imaging services were 13% to 14% lower among transparency tool users than nonusers but could not disentangle whether this was due to inherent differences between users and nonusers,4 such as educational attainment, which can also be correlated with choice of health care facility.

×